To our knowledge, the current study is the first to show that intra-articular injection of SM-MSCs could prevent arthritis development and suppress immune responses via expansion of FoxP3+ Treg cells and T2, MZ, and IL-10-competent regulatory B cells, thus recovering peripheral tolerance in mice with CIA. The gene discussed is IL10; the disease is arthritic joint disease.